Production of MMPs in human cerebral endothelial cells and their role in shedding adhesion molecules

被引:68
作者
Hummel, V
Kallmann, BA
Wagner, S
Füller, T
Bayas, A
Tonn, JC
Benveniste, EN
Toyka, KV
Rieckmann, P
机构
[1] Univ Wurzburg, Dept Neurol, Clin Res Unit Multiple Sclerosis & Neuroimmunol, D-97080 Wurzburg, Germany
[2] Univ Wurzburg, Dept Neurosurg, D-97080 Wurzburg, Germany
[3] Univ Alabama, Dept Cell Biol, Birmingham, AL USA
关键词
adhesion molecules; human cerebral endothelial cells; matrix metalloproteinases; multiple sclerosis; VCAM-1;
D O I
10.1093/jnen/60.4.320
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Matrix metalloproteinases (MMPs) are Zn2+-endopeptidases that seem to play an important role in chronic inflammatory diseases of the central nervous system by disrupting the blood-brain barrier (BBB) and mediating the destruction of myelin components. We therefore investigated the influence of the pro-inflammatory cytokine TNF-alpha on the expression and activation of several MMPs in human cerebral endothelial cells (HCEC). HCEC constitutively express MMP-2 and MMP-3 mRNA, but only MMP-3 is upregulated on mRNA and protein level after TNF-alpha stimulation. MMP-9 and MMP-12 mRNA could only be detected under inflammatory conditions. Furthermore, MMPs are involved in shedding of cell surface molecules. We therefore investigated the influence of MMPs on the release of soluble adhesion molecules using marimastat, a specific broad-spectrum MMP inhibitor and other protease inhibitors like aprotinin or leupeptin. Only marimastat inhibited the TNF-alpha mediated release of sVCAM-1 in the supernatants of HCEC. Western blot results of culture supernatants supported the time dependent release of the complete extracellular portion of the VCAM-1 molecule. These data suggest that MMPs produced by HCEC are actively involved in the shedding of soluble adhesion molecules at the BBB.
引用
收藏
页码:320 / 327
页数:8
相关论文
共 49 条
[1]
Ågren MS, 1998, BRIT J SURG, V85, P68
[2]
Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke [J].
Anthony, DC ;
Ferguson, B ;
Matyzak, MK ;
Miller, KM ;
Esiri, MM ;
Perry, VH .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1997, 23 (05) :406-415
[3]
Matrix metalloproteinase expression in an experimentally-induced DTH model of multiple sclerosis in the rat CNS [J].
Anthony, DC ;
Miller, KM ;
Fearn, S ;
Townsend, MJ ;
Opdenakker, G ;
Wells, GMA ;
Clements, JM ;
Chandler, S ;
Gearing, AJH ;
Perry, VH .
JOURNAL OF NEUROIMMUNOLOGY, 1998, 87 (1-2) :62-72
[4]
BOWMAN PD, 1981, IN VITRO CELL DEV B, V17, P353
[5]
Increases in soluble VCAM-1 correlate with a decrease in MRI lesions in multiple sclerosis treated with interferon beta-1b [J].
Calabresi, PA ;
Tranquill, LR ;
Dambrosia, JM ;
Stone, LA ;
Maloni, H ;
Bash, CN ;
Frank, JA ;
McFarland, HF .
ANNALS OF NEUROLOGY, 1997, 41 (05) :669-674
[6]
Canella B, 1995, ANN NEUROL, V27, P424
[7]
Matrix metalloproteinases degrade myelin basic protein [J].
Chandler, S ;
Coates, R ;
Gearing, A ;
Lury, J ;
Wells, G ;
Bone, E .
NEUROSCIENCE LETTERS, 1995, 201 (03) :223-226
[8]
Macrophage metalloelastase degrades matrix and myelin proteins and processes a tumour necrosis factor-alpha fusion protein [J].
Chandler, S ;
Cossins, J ;
Lury, J ;
Wells, G .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 228 (02) :421-429
[9]
Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumour necrosis factor-alpha inhibitor [J].
Clements, JM ;
Cossins, JA ;
Wells, GMA ;
Corkill, DJ ;
Helfrich, K ;
Wood, LM ;
Pigott, R ;
Stabler, G ;
Ward, GA ;
Gearing, AJH ;
Miller, KM .
JOURNAL OF NEUROIMMUNOLOGY, 1997, 74 (1-2) :85-94
[10]
HUMAN DERMAL MICROVASCULAR ENDOTHELIAL-CELLS PRODUCE MATRIX METALLOPROTEINASES IN RESPONSE TO ANGIOGENIC FACTORS AND MIGRATION [J].
CORNELIUS, LA ;
NEHRING, LC ;
ROBY, JD ;
PARKS, WC ;
WELGUS, HG .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1995, 105 (02) :170-176